Stockreport

KemPharm on go with U.S. filing for KP415 after intranasal HAP study; shares up 8% premarket [Seeking Alpha]

KemPharm, Inc.  (KMPH) 
Last kempharm, inc. earnings: 2/28 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: investors.kempharm.com/investor-overview
PDF KemPharm on go with U.S. filing for KP415 after intranasal HAP study; shares up 8% premarket [Read more]